{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:24:08Z","timestamp":1649150648940},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[1997]]},"DOI":"10.1080\/00313029700169604","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T22:21:40Z","timestamp":1128637300000},"page":"79-83","source":"Crossref","is-referenced-by-count":2,"title":["A national collaborative study of the in vitro activity of oral cephalosporins and loracarbef (LY 163892)"],"prefix":"10.1016","volume":"29","author":[{"given":"R.A.V.","family":"Benn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.R.","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/00313029700169604_bib0005","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1021\/ja00831a050","article-title":"Total synthesis of beta-lactam antibiotics. VIII. Stereospecific total synthesis of (+-)-lcarbacephalothin","volume":"96","author":"Guthikonda","year":"1974","journal-title":"J Am Chem Soc"},{"key":"10.1080\/00313029700169604_bib0010","first-page":"656","article-title":"Comparative reactivity of 1-carba-l-dethiacephalosporins with cephalosporins","volume":"331","author":"Blaszczak","year":"1990","journal-title":"J Med Chem"},{"issue":"Suppl 6A","key":"10.1080\/00313029700169604_bib0015","first-page":"165","article-title":"Pharmacokinetic profile of loracarbef","volume":"92","author":"DeSante","year":"1992","journal-title":"Am J Med"},{"key":"10.1080\/00313029700169604_bib0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jac\/22.2.155","article-title":"In vitro activity and \u03b2-lactamase stability of LY 163892","volume":"22","author":"Coa","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313029700169604_bib0025","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1128\/JCM.25.11.2105-2113.1987","article-title":"Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae","volume":"25","author":"Jorgensen","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1080\/00313029700169604_bib0030","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","article-title":"National Committee for Clinical Laboratory Standards","year":"1991"},{"key":"10.1080\/00313029700169604_bib0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF01962613","article-title":"In vitro activity and \u03b2-lactamase stability of LY 163892","volume":"7","author":"Pelosi","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1080\/00313029700169604_bib0040","first-page":"570","article-title":"\u03b2-lactamase hydrolysis and inhibition studies of the new 7-carbacephem LY 163892","volume":"6","author":"Jones","year":"1987","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1080\/00313029700169604_bib0045","series-title":"National Health and Medical Research Council","article-title":"National antimicrobial resistance surveillance program, 1992","author":"Turnidge","year":"1994"},{"key":"10.1080\/00313029700169604_bib0050","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/AAC.34.9.1783","article-title":"In vitro activities of 15 oral \u03b2-lactams against Klebsiella pneumoniae harbouring new extended-spectrum \u03b2-lactamases","volume":"34","author":"Kitzis","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029700169604_bib0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/27.3.311","article-title":"In vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid","volume":"27","author":"Arguedas","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313029700169604_bib0060","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.35.7.1504","article-title":"In vitro activity of loracarbef (LY 163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis","volume":"35","author":"Doem","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029700169604_bib0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jac\/22.4.445","article-title":"Comparative in vitro activity of a new oral carbacephem, LY 163892","volume":"22","author":"Howard","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313029700169604_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/AAC.32.1.131","article-title":"In vitro activities of LY 163892, cefaclor and cefuroxime","volume":"32","author":"Knappe","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029700169604_bib0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/AAC.32.2.268","article-title":"In vitro susceptibilities of common pediatric pathogens to LY 163892","volume":"32","author":"Shelton","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029700169604_bib0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF01962360","article-title":"In vitro activity of LY 163892 against pathogens isolated from pediatric patients","volume":"7","author":"Weneman","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1080\/00313029700169604_bib0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/AAC.34.3.467","article-title":"Comparative in vitro activities of several new fluoroquinolones and \u03b2-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae","volume":"34","author":"Mazzulli","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029700169604_bib0090","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.32.11.1738","article-title":"Pharmacokinetics of LY 163892 in infants and children","volume":"32","author":"Nelson","year":"1988","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1080\/00313029700169604_bib0095","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jac\/36.6.1043","article-title":"Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in vitro susceptibility to selected oral agents","volume":"36","author":"Mason","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313029700169604_bib0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.36.3.521","article-title":"Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams","volume":"36","author":"Van der Auwera","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029700169604_bib0105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/32.6.853","article-title":"The pharmacokinetics, tissue penetration and in vitro activity of loracarbef, a \u03b2-lattain antibiotic of the carbacephem class","volume":"32","author":"Lees","year":"1993","journal-title":"J Antimicrob Chemother"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516351029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516351029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:48:08Z","timestamp":1586497688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516351029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997]]}},"alternative-id":["S0031302516351029"],"URL":"https:\/\/doi.org\/10.1080\/00313029700169604","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}